BioLife Solutions Inc. (BJX1)
XSTU
33.20
+0.60 (+1.84%)
Closed
Oct 2, 2026
Day's Range
32.4033.60
52 wk Range
15.3034.80
Financial Statements - BJX1 - BioLife Solutions Inc.
Revenue
96.21M▲ 17.0%
Net Income
-4.59M▲ 77.2%Net Margin -4.8%
EBITDA
-11.91M▼ 312.5%
Free Cash Flow
416.00K▼ 91.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 96.21M | 82.25M | 143.27M | 161.75M | 119.15M | 48.08M |
| Cost of Goods | 34.09M | 28.58M | 96.51M | 107.93M | 82.10M | 20.64M |
| Gross Profit | 62.11M | 53.67M | 46.75M | 53.82M | 37.04M | 27.44M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -16.60M | -7.12M | -57.53M | -39.91M | -30.64M | -3.99M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 1.81M | -3.57M | -6.91M | -104.22M | 2.10M | 2.67M |
| Pre Tax Income | -12.08M | -11.42M | -66.25M | -144.82M | -29.02M | -1.28M |
| Income Tax | 49K | -38K | 169K | -5.02M | -20.11M | -3.26M |
| Net Income | -4.59M | -20.18M | -66.42M | -139.80M | -8.90M | 1.98M |
| EPS Basic | -0.09 | -0.44 | -1.52 | -3.29 | -0.22 | 0.09 |
| EPS Diluted | -0.1 | -0.44 | -1.52 | -3.29 | -0.22 | 0.03 |
| Basic Shares Outstanding | 47.75M | 46.06M | 45.84M | 44.21M | 40.07M | 28.41M |
| Diluted Shares Outstanding | 47.75M | 46.06M | 45.84M | 44.21M | 40.07M | 28.41M |
| Ebit | -16.60M | -7.12M | -57.53M | -39.91M | -30.64M | -3.99M |
| Ebitda | -11.91M | 5.60M | -37.06M | 81.49M | -19.60M | -1.60M |
| Net Income Continuous Operations | -4.59M | -20.18M | -66.42M | -139.80M | -8.90M | 1.98M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | 0 | 0 | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
